
SSRIs and Pregnancy: Navigating the Risks, Benefits, and Ongoing Debate
A new FDA panel reignites debate over the safety and efficacy of antidepressant use during pregnancy, with experts weighing in on emerging research and practice recommendations.
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.
Tag

A new FDA panel reignites debate over the safety and efficacy of antidepressant use during pregnancy, with experts weighing in on emerging research and practice recommendations.

Research highlights increased birth defect risks linked to TMP-SMX use in pregnancy, urging cautious antibiotic selection for treating UTIs.